{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:01:57Z","timestamp":1793642517253,"version":"4.5.1"},"reference-count":127,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Thyroid cancer exhibits substantial heterogeneity in its tumor immune microenvironment (TIME), which critically shapes disease progression and therapeutic responsiveness. While most differentiated thyroid cancers (DTCs) remain indolent, a subset evolves into radioiodine-refractory disease or progresses to poorly differentiated (PDTC) and anaplastic thyroid carcinoma (ATC), characterized by aggressive behavior and limited treatment options. Emerging evidence suggests that this transition is accompanied by dynamic immune reprogramming rather than static immune evasion. In this review, we propose a stepwise model of immune evolution in thyroid cancer, spanning from autoimmune-driven inflammation in chronic lymphocytic thyroiditis (CLT) to immune-exhausted states in advanced tumors. We systematically characterize immune cell composition, functional states, and regulatory networks across disease stages, highlighting key shifts in antigen presentation, T-cell functionality, and myeloid cell polarization. Building on this framework, we integrate tumor immune phenotypes (\u201chot\u201d, \u201caltered\u201d, and \u201ccold\u201d) with actionable biomarkers, including PD-L1 expression, tumor mutational burden, IFN-\u03b3 signatures, M2 macrophage-related signature, and tertiary lymphoid structures. We further map these immune contexts to rational therapeutic strategies, encompassing immune checkpoint blockade, combination regimens with tyrosine kinase inhibitors or radiotherapy, and emerging approaches such as innate immune activation and adoptive cell therapies. By linking immune evolution with therapeutic vulnerabilities, this review provides a translationally relevant framework for precision immunotherapy in thyroid cancer and highlights future directions for overcoming resistance in advanced disease.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1850228","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:13:06Z","timestamp":1782918786000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Immune evolution and therapeutic vulnerabilities in thyroid cancer: from inflammation to immune escape"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiaotong","family":"Qiu","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Shanghai Tenth People\u2019s Hospital, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhao","sequence":"additional","affiliation":[{"name":"Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao Central Hospital","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingli","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Shanghai Jiaotong University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongji","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Shanghai Tenth People\u2019s Hospital, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Shanghai Tenth People\u2019s Hospital, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanzi","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Shanghai Tenth People\u2019s Hospital, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlei","family":"Huo","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Shanghai Tenth People\u2019s Hospital, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwei","family":"Lv","sequence":"additional","affiliation":[{"name":"Shanghai Public Health Clinical Center, Fudan University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Shanghai Tenth People\u2019s Hospital, School of Medicine, Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States, 1974-2013","volume":"317","author":"Lim","year":"2017","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid cancer","volume":"388","author":"Cabanillas","year":"2016","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.76","article-title":"Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies","volume":"13","author":"Molinaro","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.101013","article-title":"Radioiodine-refractory differentiated thyroid cancer: molecular mechanisms and therapeutic strategies for radioiodine resistance","volume":"72","author":"Shen","year":"2024","journal-title":"Drug Resist Update"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0944","article-title":"2021 American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer","volume":"31","author":"Bible","year":"2021","journal-title":"Thyroid"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgp127","article-title":"Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability","volume":"30","author":"Colotta","year":"2009","journal-title":"Carcinogenesis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/nejm198612253152606","article-title":"Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing","volume":"315","author":"Dvorak","year":"1986","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1955.01270080137023","article-title":"Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland","volume":"70","author":"Dailey","year":"1955","journal-title":"AMA Arch Surg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103783","article-title":"The immune system in Hashimoto's thyroiditis: updating the current state of knowledge on potential therapies and animal model construction","volume":"24","author":"Li","year":"2025","journal-title":"Autoimmun Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"102285","DOI":"10.1016\/j.jaut.2019.05.013","article-title":"Analysis of the PD-1\/PD-L1 axis in human autoimmune thyroid disease: insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity","volume":"103","author":"\u00c1lvarez-Sierra","year":"2019","journal-title":"J Autoimmun"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1512417","article-title":"Papillary thyroid carcinoma with Hashimoto's thyroiditis: impact and correlation","volume":"16","author":"Yao","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19951201)76:11<2312::aid-cncr2820761120>3.0.co;2-h","article-title":"Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans","volume":"76","author":"Okayasu","year":"1995","journal-title":"Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0228","article-title":"Programmed death-ligand 1 expression in papillary thyroid cancer and its correlation with clinicopathologic factors and recurrence","volume":"27","author":"Shi","year":"2017","journal-title":"Thyroid"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-018-9540-9","article-title":"Papillary thyroid carcinoma emerging from Hashimoto thyroiditis demonstrates increased PD-L1 expression, which persists with metastasis","volume":"29","author":"Lubin","year":"2018","journal-title":"Endocr Pathol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12105-024-01618-5","article-title":"Chronic lymphocytic thyroiditis with oncocytic metaplasia influences PD-L1 expression in papillary thyroid carcinoma","volume":"18","author":"Santana","year":"2024","journal-title":"Head Neck Pathol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.7150\/thno.50333","article-title":"From biomarkers to therapeutic targets: the promise of PD-L1 in thyroid autoimmunity and cancer","volume":"11","author":"D'Andr\u00e9a","year":"2021","journal-title":"Theranostics"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2564","article-title":"Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer","volume":"95","author":"French","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2741\/4705","article-title":"Thyroid cancer phenotypes in relation to inflammation and autoimmunity","volume":"23","author":"Pagano","year":"2018","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111464","article-title":"NF-\u03baB in thyroid cancer: an update","volume":"25","author":"Crescenzi","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184413","article-title":"Immune and inflammatory cells in thyroid cancer microenvironment","volume":"20","author":"Ferrari","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.3390\/ijms20163934","article-title":"The immune landscape of thyroid cancer in the context of immune checkpoint inhibition","volume":"20","author":"Varricchi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/vaccines12010045","article-title":"Harnessing immunity to treat advanced thyroid cancer","volume":"12","author":"Komatsuda","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12935-021-02084-7","article-title":"The immune landscape of the microenvironment of thyroid cancer is closely related to differentiation status","volume":"21","author":"Cunha","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3803\/enm.2020.35.1.44","article-title":"Recent improvements in genomic and transcriptomic understanding of anaplastic and poorly differentiated thyroid cancers","volume":"35","author":"Yoo","year":"2020","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.637826","article-title":"Immune landscape of thyroid cancers: new insights","volume":"11","author":"Menicali","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B30","article-title":"Targeting TGF-\u03b21 suppresses survival of and invasion by anaplastic thyroid carcinoma cells","volume":"9","author":"Sun","year":"2017","journal-title":"Am J Transl Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000026138","article-title":"Immunotherapy in anaplastic thyroid cancer","volume":"12","author":"Ma","year":"2020","journal-title":"Am J Transl Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgu060","article-title":"Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8","volume":"35","author":"Fang","year":"2014","journal-title":"Carcinogenesis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1738583","DOI":"10.3389\/fimmu.2025.1738583","article-title":"Single-cell sequencing reveals the tumor immune microenvironment in thyroid cancer: a narrow review","volume":"16","author":"Liang","year":"2025"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-023-02072-w","article-title":"B cells and tertiary lymphoid structures are associated with survival in papillary thyroid cancer","volume":"46","author":"Li","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1530890","DOI":"10.3389\/fimmu.2025.1530890","article-title":"Insights into CSF-1\/CSF-1R signaling: the role of macrophage in radiotherapy","volume":"16","author":"Shang","year":"2025"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1741261","DOI":"10.3389\/fimmu.2026.1741261","article-title":"NOTCH3 attenuates cytotoxicity via RBPJ-dependent PVR upregulation to influence immunotherapy outcomes in colorectal cancer","volume":"17","author":"Ma","year":"2026"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrpr.2017.03.003","article-title":"Characteristics of lymphocyte-infiltrating papillary thyroid cancer","volume":"4","author":"Kuo","year":"2017","journal-title":"J Cancer Res Pract"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.12.3421","article-title":"The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland","volume":"80","author":"Matsubayashi","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.3.1346","article-title":"Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults","volume":"86","author":"Gupta","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2012.04482.x","article-title":"Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma","volume":"77","author":"Cunha","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12586","article-title":"CD8+ tumour-infiltrating lymphocytes and COX2 expression may predict relapse in differentiated thyroid cancer","volume":"83","author":"Cunha","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-00850-9","article-title":"IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor","volume":"22","author":"Liu","year":"2021","journal-title":"Nat Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2006.11.008","article-title":"Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal","volume":"36","author":"Tamang","year":"2006","journal-title":"Cytokine"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e169653","DOI":"10.1172\/jci169653","article-title":"Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics","volume":"133","author":"Lu","year":"2023","journal-title":"J Clin Invest"},{"key":"B46","article-title":"Defining 'T cell exhaustion'","volume":"19","author":"Blank","year":"2019"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1(+)PD-1(+)CD8(+) T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy","volume":"50","author":"Siddiqui","year":""},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nature19330","article-title":"Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy","volume":"537","author":"Im","year":""},{"key":"B49","doi-asserted-by":"publisher","first-page":"e240169","DOI":"10.1530\/erc-24-0169","article-title":"Persistent pre-exhausted CD8+ T cells shape the tumor immune microenvironment in anaplastic thyroid cancer","volume":"32","author":"Ruan","year":"2025"},{"key":"B50","doi-asserted-by":"publisher","first-page":"8375","DOI":"10.1038\/s41598-024-58419-7","article-title":"Novel T cell exhaustion gene signature to predict prognosis and immunotherapy response in thyroid carcinoma from integrated RNA-sequencing analysis","volume":"14","author":"Li","year":"2024"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-014-1222-6","article-title":"Analysis of regulatory T cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without Hashimoto's thyroiditis","volume":"17","author":"Liu","year":"2015","journal-title":"Clin Transl Oncol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3428","article-title":"Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer","volume":"97","author":"French","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-012-9853-2","article-title":"Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter","volume":"44","author":"Yu","year":"2013","journal-title":"Endocrine"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.3390\/cancers15102863","article-title":"Crosstalk between thyroid carcinoma and tumor-correlated immune cells in the tumor microenvironment","volume":"15","author":"Song","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2012(05)13","article-title":"Foxp3 expression is associated with aggressiveness in differentiated thyroid carcinomas","volume":"67","author":"Cunha","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"B56","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13046-025-03341-7","article-title":"Single-cell transcriptomics analysis reveals that the tumor-infiltrating B cells determine the indolent fate of papillary thyroid carcinoma","volume":"44","author":"Li","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.758339","article-title":"Papillary thyroid carcinoma landscape and its immunological link with Hashimoto thyroiditis at single-cell resolution","volume":"9","author":"Pan","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.imlet.2014.07.005","article-title":"The prevalence and distribution of Th17 and Tc17 cells in patients with thyroid tumor","volume":"162","author":"Jiang","year":"2014","journal-title":"Immunol Lett"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1530\/erc-13-0436","article-title":"Lymphocytic profiling in thyroid cancer provides clues for failure of tumor immunity","volume":"21","author":"Imam","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4227","article-title":"Tumor-infiltrating T cells and the PD-1 checkpoint pathway in advanced differentiated and anaplastic thyroid cancer","volume":"101","author":"Bastman","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0075","article-title":"Immune checkpoint inhibitor-induced thyroiditis is associated with increased intrathyroidal T lymphocyte subpopulations","volume":"30","author":"Kotwal","year":"2020","journal-title":"Thyroid"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03549-6","article-title":"Tumor-associated macrophages as a potential therapeutic target in thyroid cancers","volume":"72","author":"Zhu","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.4132\/jptm.2015.06.01","article-title":"Cancers with higher density of tumor-associated macrophages were associated with poor survival rates","volume":"49","author":"Jung","year":"2015","journal-title":"J Pathol Transl Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3803\/enm.2013.28.3.178","article-title":"The expression of tumor-associated macrophages in papillary thyroid carcinoma","volume":"28","author":"Kim","year":"2013","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2012.0261","article-title":"Expression of decoy receptor 3 in diffuse sclerosing variant of papillary thyroid carcinoma: correlation with M2 macrophage differentiation and lymphatic invasion","volume":"23","author":"Chang","year":"2013","journal-title":"Thyroid"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/srep14273","article-title":"Opposite effects of M1 and M2 macrophage subtypes on lung cancer progression","volume":"5","author":"Yuan","year":"2015","journal-title":"Sci Rep"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1186\/1757-2215-7-19","article-title":"A high M1\/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients","volume":"7","author":"Zhang","year":"2014","journal-title":"J Ovarian Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.03.048","article-title":"Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer","volume":"181","author":"Zhang","year":"2020"},{"key":"B70","doi-asserted-by":"publisher","first-page":"152821","DOI":"10.1016\/j.imbio.2024.152821","article-title":"APOE expression in papillary thyroid carcinoma: Influencing tumor progression and macrophage polarization","volume":"229","author":"Huo","year":""},{"key":"B71","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/biomedicines14020294","article-title":"SPP1+ macrophages and the orchestration of spatially organized immunosuppression in cancer","volume":"14","author":"Li","year":"2026"},{"key":"B72","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41392-026-02672-x","article-title":"Lactate metabolism and lactylation in cancer: from pathogenesis to therapeutic advances","volume":"11","author":"Fang","year":"2026"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e789","DOI":"10.1002\/mco2.789","article-title":"Immunometabolism: signaling pathways, homeostasis, and therapeutic targets","volume":"5","author":"Xu","year":"2024"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.01.021","article-title":"IL-10-producing B cells in differentiated thyroid cancer suppress the effector function of T cells but improve their survival upon activation","volume":"376","author":"Wang","year":"2019","journal-title":"Exp Cell Res"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64951-6","article-title":"Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells","volume":"156","author":"Scarpino","year":"2000","journal-title":"Am J Pathol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1309\/ajcpakydo56nkmyz","article-title":"The role of s100-positive dendritic cells in the prognosis of papillary thyroid carcinoma","volume":"139","author":"Hilly","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2015.05.009","article-title":"CD1a-positive dendritic cell density predicts disease-free survival in papillary thyroid carcinoma","volume":"211","author":"Hilly","year":"2015","journal-title":"Pathol Res Pract"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1530\/erc-17-0316","article-title":"Immune responses in the thyroid cancer microenvironment: making immunotherapy a possible mission","volume":"24","author":"Mould","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1838","article-title":"Phenotypical analysis of lymphocytes with suppressive and regulatory properties (Tregs) and NK cells in the papillary carcinoma of thyroid","volume":"97","author":"Gogali","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-14-0291","article-title":"Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2\/5\/6 and chemoattract NK cells","volume":"20","author":"Wennerberg","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.09.016","article-title":"Dysfunction of natural killer cells mediated by PD-1 and Tim-3 pathway in anaplastic thyroid cancer","volume":"64","author":"Yin","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.4174\/astr.2015.88.4.187","article-title":"The neutrophil to lymphocyte ratio can discriminate anaplastic thyroid cancer against poorly or well differentiated cancer","volume":"88","author":"Cho","year":"2015","journal-title":"Ann Surg Treat Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-014-2630-z","article-title":"Does preoperative neutrophil lymphocyte ratio predict risk of recurrence and occult central nodal metastasis in papillary thyroid carcinoma","volume":"38","author":"Lang","year":"2014","journal-title":"World J Surg"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199740","article-title":"Potential involvement of neutrophils in human thyroid cancer","volume":"13","author":"Galdiero","year":"2018","journal-title":"PloS One"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.348","article-title":"Mast cells have a protumorigenic role in human thyroid cancer","volume":"29","author":"Melillo","year":"2010","journal-title":"Oncogene"},{"key":"B88","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2217\/imt-2016-0135","article-title":"Tumor-associated macrophages: implications in cancer immunotherapy","volume":"9","author":"Petty","year":"2017","journal-title":"Immunotherapy"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2014.441","article-title":"Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway","volume":"34","author":"Visciano","year":"2015","journal-title":"Oncogene"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01167","article-title":"Immune profiling of thyroid carcinomas suggests the existence of two major phenotypes: an ATC-like and a PDTC-like","volume":"104","author":"Giannini","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34657","article-title":"Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study","volume":"129","author":"Oh","year":"2023","journal-title":"Cancer"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0322","article-title":"Combination of Lenvatinib and Pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma","volume":"31","author":"Dierks","year":"2021","journal-title":"Thyroid"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2024.2395067","article-title":"Local therapy with combination TLR agonists stimulates systemic anti-tumor immunity and sensitizes tumors to immune checkpoint blockade","volume":"13","author":"Rwandamuriye","year":"2024","journal-title":"Oncoimmunology"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2017.0227","article-title":"Insights into the management of papillary microcarcinoma of the thyroid","volume":"28","author":"Miyauchi","year":"2017"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1200\/jco.19.02727","article-title":"PD-1 blockade in anaplastic thyroid carcinoma","volume":"38","author":"Capdevila","year":"2020","journal-title":"J Clin Oncol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1200\/jco.20.01437","article-title":"Immunotherapy for anaplastic thyroid carcinoma","volume":"38","author":"Lim","year":"2020","journal-title":"J Clin Oncol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2021.1964189","article-title":"Characterization of immune landscape in papillary thyroid cancer reveals distinct tumor immunogenicity and implications for immunotherapy","volume":"10","author":"Sun","year":"2021","journal-title":"Oncoimmunology"},{"key":"B98","doi-asserted-by":"publisher","first-page":"6093","DOI":"10.1200\/jco.2022.40.16_suppl.6093","article-title":"Phase I study of AIC100 in relapsed and\/or refractory advanced thyroid cancer and anaplastic thyroid cancer","volume":"40","author":"Hsu","year":"2022","journal-title":"J Clin Oncol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"6095","DOI":"10.1200\/jco.2023.41.16_suppl.6095","article-title":"Safety and early efficacy results of phase 1 study of affinity tuned and trackable AIC100 CAR T cells in ICAM-1 positive relapsed and\/or refractory advanced poorly differentiated and anaplastic thyroid cancers","volume":"41","author":"Srour","year":"2023","journal-title":"J Clin Oncol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/921864","article-title":"CD8+ TIL recruitment may revert the association of MAGE A3 with aggressive features in thyroid tumors","volume":"2014","author":"Martins","year":"2014","journal-title":"J Immunol Res"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01678-9","article-title":"Decoding the tumor microenvironment with spatial technologies","volume":"24","author":"Walsh","year":"2023","journal-title":"Nat Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1711015","DOI":"10.3389\/fimmu.2025.1711015","article-title":"SPP1(+) macrophages in tumor immunosuppression: mechanisms and therapeutic implications","volume":"16","author":"Wang","year":"2025"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.04.014","article-title":"Conserved pan-cancer microenvironment subtypes predict response to immunotherapy","volume":"39","author":"Bagaev","year":"2021"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.929091","article-title":"What is the status of immunotherapy in thyroid neoplasms","volume":"13","author":"Garcia-Alvarez","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B106","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40425-018-0378-y","article-title":"Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma","volume":"6","author":"Iyer","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0296-2","article-title":"Combinations of BRAF inhibitor and anti-PD-1\/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer","volume":"119","author":"Gunda","year":"2018","journal-title":"Br J Cancer"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-20-1523","article-title":"PD1 blockade enhances ICAM1-directed CAR T therapeutic efficacy in advanced thyroid cancer","volume":"26","author":"Gray","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B109","doi-asserted-by":"publisher","first-page":"6587","DOI":"10.1200\/jco.2020.38.15_suppl.6587","article-title":"Radioiodine (RAI) in combination with durvalumab for recurrent\/metastatic thyroid cancers","volume":"38","author":"Burman","year":"2020","journal-title":"J Clin Oncol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2019.0086","article-title":"A phase 2 study of pembrolizumab combined with chemoradiotherapy as initial treatment for anaplastic thyroid cancer","volume":"29","author":"Chintakuntlawar","year":"2019","journal-title":"Thyroid"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3390\/cancers11101532","article-title":"Virotherapy as a potential therapeutic approach for the treatment of aggressive thyroid cancer","volume":"11","author":"Malfitano","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw640","article-title":"Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer","volume":"28","author":"Osorio","year":"2017"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw443","article-title":"Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab","volume":"28","author":"Menzies","year":"2017"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2021.03.036","article-title":"Predictive biomarkers for response to immune checkpoint inhibition","volume":"79","author":"Shum","year":"2022"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1411300","article-title":"CAR-T cell therapy in advanced thyroid cancer: from basic to clinical","volume":"15","author":"Sun","year":"2024","journal-title":"Front Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"10634","DOI":"10.1038\/s41598-019-46938-7","article-title":"Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy","volume":"9","author":"Vedvyas","year":"2019","journal-title":"Sci Rep"},{"key":"B118","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1385\/ep:17:1:45","article-title":"Expression of MAGE tumor-associated antigen in thyroid carcinomas","volume":"17","author":"Milkovic","year":"2006","journal-title":"Endocr Pathol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1997.7.725","article-title":"MUC1 mucin gene, transcripts, and protein in adenomas and papillary carcinomas of the thyroid","volume":"7","author":"Bi\u00e8che","year":"1997","journal-title":"Thyroid"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1172\/jci85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers","volume":"126","author":"Landa","year":"2016","journal-title":"J Clin Invest"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.10.4965","article-title":"Immunotherapy for medullary thyroid carcinoma by dendritic cell vaccination","volume":"86","author":"Schott","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2013.0680","article-title":"A potential role for immunotherapy in thyroid cancer by enhancing NY-ESO-1 cancer antigen expression","volume":"24","author":"Gunda","year":"2014","journal-title":"Thyroid"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0460","article-title":"Management guidelines for children with thyroid nodules and differentiated thyroid cancer","volume":"25","author":"Francis","year":"2015"},{"key":"B124","doi-asserted-by":"publisher","first-page":"101715","DOI":"10.1016\/j.beem.2022.101715","article-title":"Pediatric thyroid cancer: recent developments","volume":"37","author":"Cherella","year":"2023"},{"key":"B125","doi-asserted-by":"publisher","first-page":"e04088","DOI":"10.1002\/advs.202504088","article-title":"Single-cell transcriptomics reveals ITGA2-mediated metabolic reprogramming and immune crosstalk in pediatric thyroid carcinogenesis","volume":"12","author":"Zhan","year":"2025"},{"key":"B126","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3390\/ph17080991","article-title":"Immune checkpoint inhibitors for pediatric cancers: is it still a stalemate","volume":"17","author":"Jaing","year":"2024"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40272-021-00482-y","article-title":"Immunotherapies for pediatric solid tumors: a targeted update","volume":"24","author":"Gupta","year":"2022","journal-title":"Pediatr Drugs"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1850228\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:13:08Z","timestamp":1782918788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1850228\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":127,"alternative-id":["10.3389\/fimmu.2026.1850228"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1850228","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"article-number":"1850228"}}